BT

Bas Trietsch

Chief Technology Officer

MIMETAS

The Hague


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
MIMETAS
Industry
research
Employees
91.0
Seniority
C suite
Annual Revenue
20000000.0
Total Funding
29378260.0
Latest Funding
Other

Technologies

Cloudflare DNS Outlook Pardot ExactOnline MailChimp SPF Microsoft Office 365 Zendesk CloudFlare Hosting Gmail Google Apps Amazon AWS Drupal Stripe Exact Online Salesforce Mobile Friendly Google Dynamic Remarketing Hotjar DoubleClick Google Analytics Bing Ads DoubleClick Conversion Piwik Twitter Advertising LiveChat Linkedin Marketing Solutions Google Tag Manager

Keywords

organonachip microfluidics 3d cell culture cellbased assays toxicology tissue models disease models microphysiological systems mps organoids bloodbrain barrier liver brain models liver models kidney models 3d disease modeling phenotypic screening highthroughput biotechnology research human tissue models drug discovery 3d tissue culture phenotypic modeling therapy prioritization organocore discovery platform assay services preclinical research car t cell assay services inflammatory bowel disease organoready toxicology studies biomarker predictability patient relevant models cancer research tumor microenvironment cell-based assays high throughput screening automated cell seeding patient-derived tumor cells microvascularized models immunotherapy tumor models drug interaction studies customized solutions customized fee-for-service compounds validation cellular assays organoplate technology angiogenesis assays therapeutic optimization oncology services modular cell culture biological complexity pharmacokinetics preclinical models ethical alternatives to animal testing tumor killing efficacy real-time visualization immune cell migration cancer biology cellular behavior patient specific modeling 3d organ models innovative discovery translatable research biopharmaceutical partnerships disease mechanisms biotechnology organ-on-a-chip organoplate 3d tissue models drug development personalized medicine chemical testing food safety high-throughput screening human disease modeling tissue culture continuous perfusion therapeutic innovation animal-free research assay development pharmaceutical industry biotech firms disease biology safety testing compound screening metabolic homeostasis co-culture systems automated imaging research institutions global reach innovative technology customer-centric solutions strategic partnerships advanced biological testing predictive modeling therapeutic candidates efficacy assessment safety evaluation

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans